Preferred Name |
liraglutide |
|
Synonyms |
Victoza Saxenda NN-2211 |
|
Definitions |
Any condition in which the main influencing factor is liraglutide, a lipopeptide that is an analogue of human GLP-1 and an agonist of the GLP-1 receptor. Liraglutide is used as a hypoglycemic agent and supplemental therapy in the treatment of diabetes mellitus. |
|
ID |
http://purl.obolibrary.org/obo/XCO_0000907 |
|
created_by |
slaulede |
|
creation_date |
2021-10-15T10:42:36Z |
|
database_cross_reference |
PMID:29976929 |
|
definition |
Any condition in which the main influencing factor is liraglutide, a lipopeptide that is an analogue of human GLP-1 and an agonist of the GLP-1 receptor. Liraglutide is used as a hypoglycemic agent and supplemental therapy in the treatment of diabetes mellitus. |
|
has_exact_synonym |
Victoza Saxenda NN-2211 |
|
has_obo_namespace |
experimental_condition_ontology |
|
id |
XCO:0000907 |
|
label |
liraglutide |
|
notation |
XCO:0000907 |
|
prefLabel |
liraglutide |
|
treeView | ||
subClassOf |
Create mapping